We are delighted to announce that on April 5, 2024, the results of an observational study comparing a brand-new point-of-care fluorescence immunoassay for determining circulating levels of vitamin D with ultra-high performance liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) were published in the prestigious peer-reviewed journal "Molecules."
Vitamin D deficiency and insufficiency, which can lead to many pathological conditions, have become a widespread health problem, resulting in an increase in requests for determining circulating levels of 25-hydroxyvitamin D (25-OH-D), that is currently the main indicator of vitamin D status and it is performed by different assays. However, the analytical performance of these immunoassays is highly variable and does not necessarily provide comparable results. To address this issue, considerable efforts have been made to improve the metrological performance of this test to achieve comparable results across different methods and manufacturers.
In particular, the AFIAS Vit D assay, a point-of-care fluorescence immunoassay based on a single cartridge with a lateral flow architecture and pre-filled with all the necessary reagents for the test, showed a good correlation with LC-MS/MS when running on both the Afias-1 and Afias-10 analyzers (Boditech and Menarini).
Therefore, we can confidently assert that AFIAS-1 and AFIAS-10 are reliable instruments for accurately and rapidly measuring 25-OH-D levels.
#innovation #healthcare #technology
Full Pdf link: https://lnkd.in/dSHVAyXf
"Head of Marketing, Product Management & Scientific Support | Driving Innovation & Strategic Growth in Healthcare Diagnostics"
3wVery informative